Sjögren's disease trials in Canada

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  Where

  Rimouski, Sherbrooke, Sydney

  Age

  18 years and over

  People

  570 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07621809 · EU 2025-522271-29-00
• Phase 2Taking people
  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  Where

  Rimouski, Sherbrooke, Trois-Rivières

  Age

  18 years to 100 years

  People

  344 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07737743 · EU 2025-524513-92-00
• Phase 1Taking people
  Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  Where

  Toronto

  Age

  18 years and over

  People

  300 worldwide

  Run by

  National Cancer Institute (NCI)

  See details and how to joinNCT03816345
• Phase 3Taking people
  A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  Where

  Trois-Rivières

  Age

  18 years and over

  People

  844 worldwide

  Run by

  Amgen

  See details and how to joinNCT06747949 · EU 2024-517513-32-00